Skip to main content
OpenTrials
Completed

NCT Number: NCT01901003

Sedative Premedication: Efficacy On Patient Experience

Seven French university hospitals will participate in this multicentric prospective, blinded and randomized study. The investigators designed 3 study groups: Lorazepam 2.5mg, Placebo (microcrystalline celluloses) and no premedication at all. The third group (no premedication) is necessary in order to evaluate a placebo response, which may be significant on anxiety level and patients perceptions of care. It was calculated that 969 patients had to be included in order to obtain a 5 point difference between groups on the EVAN score with 80 % statistical power, leading to the inclusion of 1200 patients with an estimated maximum dropout rate of 15 %. All adults below 70 years and scheduled for elective surgery under general anesthesia can be included after information by an anesthesiologist in charge of the study and written informed consent. Non inclusion criterions are: a weight below 45 Kg, a counter indication to benzodiazepine, surgeries that could impair cognitive functions (cardiac or neurologic surgery), usual use of neuroleptics or lithium, drug addiction or former cognitive disease. The technique of anesthesia will be decided by the attending anesthesiologist, who will be unaware of the premedication technique, independently of the study protocol.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Perioperative Anxiety

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Assistance Publique Hopitaux de Marseille

Marseille, 13354, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • male or female aged 18 to 70 years or more;
  • About a weight greater than 45 kg;
  • Subject to benefit from a scheduled surgery under general anesthesia;
  • Topic respecting the ambivalence clause defined below:
  • Having no cons-indication to the use of benzodiazepines;
  • Having no known allergy to benzodiazepines;
  • May be a candidate for the prescription of premedication;
  • Topic able to complete a self-administered questionnaire;
  • Subject has signed a written informed consent and agreeing to abide by the instructions of the Protocol

Exclusion criteria

  • - Topic of over 70 years;
  • Topic 45 kg or less;
  • Topic demanding to receive anxiolytic premedication;
  • Subject severe respiratory insufficiency;
  • Topic minor, pregnant or breastfeeding, about not being affiliated to the social security system;
  • Topic for which surgery is performed under local anesthesia;
  • Subject unable to perform only a self-administered questionnaire (inability to read French, severe cognitive impairment);
  • Subject to which the scheduled surgery may cause postoperative cognitive dysfunction (intracranial surgery, extracorporeal circulation);
  • Topic scheduled for obstetrical surgery or outpatient;
  • Subject treated with antipsychotic (neuroleptic or lithium);
  • Subject with cognitive impairment already documented (Alzheimer, dementia, neurological sequelae);
  • Subject active consumer of narcotics;
  • Subject has not signed informed consent.

Treatment and study plan

Lorazepam

Drug

no premedication

Other

Placebo (microcrystalline celluloses)

Drug

Primary outcomes

  1. the EVAN score

    Time frame: 2 years

    to evaluate patient satisfaction of the perioperative period

Secondary outcomes

  1. the perioperative level of anxiety

    Time frame: 2 years

    APAIS score (Moerman 1996) before surgery

Sponsors and collaborators

Lead sponsor

Assistance Publique Hopitaux De Marseille

Other

Registry information

Acronym: PremedX

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
Jul 17, 2013
Registry last updated
Apr 21, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.